Bausch Health Companies (BHC) Return on Capital Employed Growth (1y) (2011 - 2026)
Bausch Health Companies (BHC) Return on Capital Employed Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.88 Bn | 87.01 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.92 Bn | 32.18 Bn | 1.97 Bn | 696.00 |
| 3 | Zoetis | 32.31 Bn | 30.37 Bn | 1.62 Bn | -507.00 |
| 4 | Takeda Pharmaceutical | 27.54 Bn | 23.48 Bn | 4.39 Bn | -723.00 |
| 5 | United Therapeutics | 23.07 Bn | 20.91 Bn | 648.10 Mn | 89.00 |
| 6 | RedHill Biopharma | 20.53 Bn | 20.53 Bn | - | - |
| 7 | Viatris | 20.27 Bn | 18.47 Bn | 1.16 Bn | 944.00 |
| 8 | Neurocrine Biosciences | 17.92 Bn | 16.61 Bn | 800.70 Mn | 448.00 |
| 9 | Elanco Animal Health | 12.61 Bn | 12.18 Bn | 785.00 Mn | 1,195.00 |
| 10 | Bausch Health Companies | 1.68 Bn | 365.34 Mn | 2.52 Bn | -413.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -413.00 |
| Dec 31, 2025 | 27.00 |
| Sep 30, 2025 | 239.00 |
| Jun 30, 2025 | 261.00 |
| Mar 31, 2025 | 223.00 |
| Dec 31, 2024 | 361.00 |
| Sep 30, 2024 | 448.00 |
| Jun 30, 2024 | 192.00 |
| Mar 31, 2024 | 311.00 |
| Dec 31, 2023 | 215.00 |
| Sep 30, 2023 | -286.00 |
| Jun 30, 2023 | -310.00 |
| Mar 31, 2023 | -233.00 |
| Dec 31, 2022 | 19.00 |
| Sep 30, 2022 | 419.00 |
| Jun 30, 2022 | 602.00 |
| Mar 31, 2022 | 312.00 |
| Dec 31, 2021 | -68.00 |
| Sep 30, 2021 | 180.00 |
| Jun 30, 2021 | 464.00 |